Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma - Wikidata - wikimedia - TriplyDB

Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma

Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma

http://www.wikidata.org/entity/Q34121782

about

DNA hybridization detection with 100 zM sensitivity using piezoelectric plate sensors with an improved noise-reduction algorithm.Aberrant fatty acid-binding protein-7 gene expression in cutaneous malignant melanoma.Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.Estrogen receptor-alpha methylation predicts melanoma progression Epigenetic biomarkers in skin cancer.Circulating Tumor Cells, DNA, and mRNA: Potential for Clinical Utility in Patients With Melanoma.Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma.Prognostic molecular biomarkers for cutaneous malignant melanoma Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology.Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy Liquid Biopsies for Assessing Metastatic Melanoma Progression.Circulating tumor cells in uveal melanoma.Blood biomarkers for uveal melanoma.Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients Bov-tA short interspersed nucleotide element sequences in circulating nucleic acids from sera of cattle with bovine spongiform encephalopathy (BSE) and sera of cattle exposed to BSE.Quantification of Plasma Cell-Free Circulating DNA at Different Stages of Colorectal Cancer.

P2860

Q27336155-B12BEEC6-44B3-4A19-9510-D9C518A2E66B Q33754941-EE7D6712-E88D-4CA9-9232-6A2CB03D9756 Q33796956-79DDB308-0775-475C-930F-52C84F3A0ACF Q33797076-8813FA3F-8EF7-4744-BA85-2DFD36BEC7D8 Q36080974-D7BEB1C5-B20D-492A-9C9E-405D5C3D5F74 Q36452245-401C6F93-4761-4A4D-956D-147BF4B87479 Q36616022-59EC4D19-4A89-48DE-9010-725D340C07AB Q36905877-4722A67C-27D1-45FD-A462-E9BA958E6713 Q37014663-A3207F92-111B-49AC-84FB-39E256DB386A Q37286893-B01437B1-DB51-4FE3-8B29-0AEDFB806836 Q37667080-E37B7A5D-A00E-43F3-BE35-D57465A44A34 Q37822739-F25AACCD-8BD3-40C7-9B14-BAD85261CC22 Q37984126-63E00DEE-7999-4913-AF79-B08C7066905E Q38152782-EBCC6D9D-DF35-4B3A-80BD-1D8478937F23 Q38700529-C8B0F72C-3C10-47C2-8CC4-F118B661986E Q42930625-AFD1A41C-AA87-4A2D-8A78-E8B15A73409F Q49826552-5DE3C6F8-9D83-4F18-B727-50FE588DB474

P2860

Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma

http://www.wikidata.org/entity/Q34121782

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Circulating DNA microsatellite ...... ients with metastatic melanoma

@ast

Circulating DNA microsatellite ...... ients with metastatic melanoma

@en

Circulating DNA microsatellite ...... ients with metastatic melanoma

@nl

type

label

Circulating DNA microsatellite ...... ients with metastatic melanoma

@ast

Circulating DNA microsatellite ...... ients with metastatic melanoma

@en

Circulating DNA microsatellite ...... ients with metastatic melanoma

@nl

prefLabel

Circulating DNA microsatellite ...... ients with metastatic melanoma

@ast

Circulating DNA microsatellite ...... ients with metastatic melanoma

@en

Circulating DNA microsatellite ...... ients with metastatic melanoma

@nl

P1433

Q34121782-BE006456-2231-45D3-973F-A9A8D52AD7D0

P1476

Q34121782-D27559C4-F2A1-4DEA-AF6F-C4C4F305B7DB

P2093

Q34121782-4EC21F29-7A69-488F-8EDC-5E955998FC6B

Q34121782-9B23DC48-1E6D-46BF-B0BC-048360DD498A

Q34121782-A6DDB9C2-818D-42E5-879A-BD23A4F3063A

Q34121782-B57BD1F4-40AC-44FC-9B07-8852536CDB33

Q34121782-BF5E4433-6818-42BC-A805-A729A18D523A

Q34121782-C112685A-928D-4E75-AA59-31F7D8A6AE7C

Q34121782-D5773C72-1F43-40A7-9BD8-74B0E0D64FA6

P2860

Q34121782-08765AA1-30C8-4362-857F-ED82EBB5FCBF

Q34121782-11C2428F-14D5-4889-AA7A-A18C80E8F65B

Q34121782-15A7337B-C84C-4AE1-9B06-99092D03C00F

Q34121782-218E3C4C-AFC5-4504-BF1C-CBDE3944FC35

Q34121782-34BE6618-D6D8-4E55-8658-E417A4B08192

Q34121782-3AAEE3D1-B1A8-43B6-8E49-CFA2B690E010

Q34121782-54BC6B72-558A-49A4-8D67-9231C208EA3E

Q34121782-567990F5-2A6A-4CBA-A335-298F7C07FFCF

Q34121782-648C5333-AE13-4754-AD18-6D4772801B3A

Q34121782-6EAA825A-6B7C-4762-BC78-159235D24E52

P304

Q34121782-403B9AD2-6A1E-4DAE-942C-4578193D04C6

P31

Q34121782-EDD5EB4E-B05C-413C-8B83-09429B11F048

P356

Q34121782-EA389454-3F77-40F1-8DAF-659DA0668347

P407

Q34121782-4BC573C9-0B98-485F-884F-10F120797364

P433

Q34121782-3BF38533-0CB0-4A7E-9C2F-1B57C058AC70

P478

Q34121782-F9CBC021-1C07-4039-8662-4A23258947A8

P50

Q34121782-417a1c7c-449d-ebc2-8727-633c94e5b3c3

P577

Q34121782-4EDC4638-13A2-4530-BB15-9B9FDA2E9B9C

P5875

Q34121782-B939E227-EE29-43F1-93B8-B8CF6F8A357D

P698

Q34121782-29308AD6-47C3-4250-B8CB-8FBD96408E84

P921

Q34121782-A2391D91-FB00-4320-A102-5C4D081BAAD1

P932

Q34121782-E4827751-2657-4A9C-9B11-12A76661CF15

P356

P1433

Journal of the National Cancer Institute

P1476

Circulating DNA microsatellite ...... ients with metastatic melanoma

@en

P2093

Bret Taback

http://www.w3.org/2001/XMLSchema#string

Dave S B Hoon

http://www.w3.org/2001/XMLSchema#string

He-Jing Wang

http://www.w3.org/2001/XMLSchema#string

Patricia Fournier

http://www.w3.org/2001/XMLSchema#string

Peter D Boasberg

http://www.w3.org/2001/XMLSchema#string

Sherry Shu

http://www.w3.org/2001/XMLSchema#string

Steven J O'Day

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular clonality of in-transit melanoma metastasis.

Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma.

Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy.

Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis.

Practical guidelines for the management of biochemotherapy-related toxicity in melanoma.

Microsatellite alterations in plasma DNA of small cell lung cancer patients.

Microsatellite alterations in serum DNA of head and neck cancer patients.

Metastatic melanoma: chemotherapy to biochemotherapy.

Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene.

Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit

P304

152-156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJH011

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

Robert Elashoff

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8909839

http://www.w3.org/2001/XMLSchema#string

P698

14734706

http://www.w3.org/2001/XMLSchema#string

P921

P932

2938022

http://www.w3.org/2001/XMLSchema#string